CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 

Moderna Inc 's Quick Ratio

MRNA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




MRNA Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change 5368.71 % 6176.76 % 42480.85 % 15523 % 3032.69 %
Y / Y Cash & cash equivalent Change 194.07 % 535.21 % 9215116 % 121605.13 % 165168.43 %
Quick Ratio MRQ 0.9 0.92 1.05 2.22 16.81
Overall Ranking # # # # #
Seq. Current Liabilities Change 4.65 % 92.48 % 197.84 % 811.59 % 20.11 %
Seq. Cash & cash equivalent Change 3.3 % 67.87 % 40.63 % 20.58 % 123.13 %



Quick Ratio second quarter 2021 Comment
Due to increase in Current Liabilities in the second quarter 2021, Quick Ratio fell to 0.9 below Moderna Inc average.

Within Biotechnology & Pharmaceuticals industry 71 other companies have achieved higher Quick Ratio than Moderna Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are MRNA Segments?
See Quick Ratio MRNA on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 72
Healthcare Sector # 270
Overall Market # 849


Quick Ratio Statistics
High Average Low
16.81 1.3 0
(Jun 30 2020)   (Sep 30 2017)




Financial Statements
Moderna Inc 's Current Liabilities $ 8,840 Millions Visit MRNA's Balance sheet
Moderna Inc 's Cash & cash equivalent $ 7,990 Millions Visit MRNA's Balance sheet
Source of MRNA's Sales Visit MRNA's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within Biotechnology & Pharmaceuticals Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Adma Biologics Inc   2.40 $ 42.409  Millions$ 17.658  Millions
Axon Enterprise inc   2.40 $ 655.267  Millions$ 272.871  Millions
Chromadex Corporation  2.39 $ 38.778  Millions$ 16.229  Millions
Procyon Corp  2.36 $ 1.507  Millions$ 0.638  Millions
Amyris Inc   2.26 $ 214.424  Millions$ 94.837  Millions
Repligen Corp  2.24 $ 734.327  Millions$ 328.099  Millions
Apollo Endosurgery inc   2.11 $ 30.541  Millions$ 14.448  Millions
Cannabics Pharmaceuticals Inc   2.01 $ 2.949  Millions$ 1.470  Millions
Aptevo Therapeutics Inc   1.96 $ 60.394  Millions$ 30.864  Millions
Biocryst Pharmaceuticals Inc  1.93 $ 222.776  Millions$ 115.601  Millions
Eyenovia inc   1.87 $ 27.296  Millions$ 14.560  Millions
Fulgent Genetics Inc   1.85 $ 100.461  Millions$ 54.205  Millions
Aerie Pharmaceuticals Inc   1.74 $ 188.287  Millions$ 108.086  Millions
Cerecor Inc   1.71 $ 40.476  Millions$ 23.674  Millions
Coherus Biosciences inc   1.58 $ 454.421  Millions$ 287.052  Millions
Azurrx Biopharma Inc   1.56 $ 8.144  Millions$ 5.204  Millions
Bio techne Corp  1.52 $ 231.554  Millions$ 152.284  Millions
Vaxart Inc   1.51 $ 19.318  Millions$ 12.780  Millions
Cidara Therapeutics Inc   1.42 $ 48.284  Millions$ 33.887  Millions
Immunitybio Inc   1.40 $ 103.928  Millions$ 74.428  Millions
Biorestorative Therapies Inc   1.33 $ 1.759  Millions$ 1.326  Millions
Surgalign Holdings Inc   1.31 $ 69.257  Millions$ 52.799  Millions
Novavax inc   1.28 $ 2,121.278  Millions$ 1,651.516  Millions
Aziyo Biologics inc   1.20 $ 28.302  Millions$ 23.596  Millions
Emergent Biosolutions Inc   1.18 $ 447.500  Millions$ 377.800  Millions
Pharmacyte Biotech Inc   1.04 $ 0.959  Millions$ 0.925  Millions
Outlook Therapeutics Inc   1.00 $ 19.692  Millions$ 19.639  Millions
Svf Investment Corp 3  0.93 $ 2.707  Millions$ 2.902  Millions
Moderna Inc   0.90 $ 7,990.000  Millions$ 8,840.000  Millions
Boston Therapeutics Inc   0.89 $ 3.960  Millions$ 4.440  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PATH's Profile

Stock Price

PATH's Financials

Business Description

Fundamentals

Charts & Quotes

PATH's News

Suppliers

PATH's Competitors

Customers & Markets

Economic Indicators

PATH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071